Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Common Equity: 2020-2024

Historic Common Equity for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $336.0 million.

  • Cellebrite DI's Common Equity rose 50.07% to $447.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.7 million, marking a year-over-year increase of 50.07%. This contributed to the annual value of $336.0 million for FY2024, which is 882.17% up from last year.
  • As of FY2024, Cellebrite DI's Common Equity stood at $336.0 million, which was up 882.17% from $34.2 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Common Equity registered a high of $336.0 million during FY2024, and its lowest value of -$73.3 million during FY2021.
  • For the 3-year period, Cellebrite DI's Common Equity averaged around $148.0 million, with its median value being $73.9 million (2022).
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 214.96% in 2021, then surged by 882.17% in 2024.
  • Over the past 5 years, Cellebrite DI's Common Equity (Yearly) stood at $63.8 million in 2020, then tumbled by 214.96% to -$73.3 million in 2021, then spiked by 200.71% to $73.9 million in 2022, then crashed by 53.68% to $34.2 million in 2023, then surged by 882.17% to $336.0 million in 2024.